Hyperspectral imaging of bruised skin

Lise L. Randeberg; Ivar Baarstad; Trond Løke; Peter Kaspersen; Lars O. Svaasand

doi:10.1117/12.646557

22 February 2006 Hyperspectral imaging of bruised skin

Lise L. Randeberg, Ivar Baarstad, Trond Løke, Peter Kaspersen, Lars O. Svaasand

Proceedings Volume 6078, Photonic Therapeutics and Diagnostics II; 60780O (2006) https://doi.org/10.1117/12.646557
Event: SPIE BiOS, 2006, San Jose, California, United States

Abstract

Bruises can be important evidence in legal medicine, for example in cases of child abuse. Optical techniques can be used to discriminate and quantify the chromophores present in bruised skin, and thereby aid dating of an injury. However, spectroscopic techniques provide only average chromophore concentrations for the sampled volume, and contain little information about the spatial chromophore distribution in the bruise. Hyperspectral imaging combines the power of imaging and spectroscopy, and can provide both spectroscopic and spatial information. In this study a hyperspectral imaging system developed by Norsk Elektro Optikk AS was used to measure the temporal development of bruised skin in a human volunteer. The bruises were inflicted by paintball bullets. The wavelength ranges used were 400 - 1000 nm (VNIR) and 900 - 1700 nm (SWIR), and the spectral sampling intervals were 3.7 and 5 nm, respectively. Preliminary results show good spatial discrimination of the bruised areas compared to normal skin. Development of a white spot can be seen in the central zone of the bruises. This central white zone was found to resemble the shape of the object hitting the skin, and is believed to develop in areas where the impact caused vessel damage. These results show that hyperspectral imaging is a promising technique to evaluate the temporal and spatial development of bruises on human skin.

Citation Download Citation

Lise L. Randeberg, Ivar Baarstad, Trond Løke, Peter Kaspersen, and Lars O. Svaasand "Hyperspectral imaging of bruised skin", Proc. SPIE 6078, Photonic Therapeutics and Diagnostics II, 60780O (22 February 2006); https://doi.org/10.1117/12.646557

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available